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Multiple studies have reported an association
between attention deficit hyperactivity disorder
(ADHD) and the 10-repeat allele of a variable
number tandem repeat (VNTR) polymorphism in
the 30-untranslated region (30UTR) of the dopa-
mine transporter gene (DAT1). Yet, recent meta-
analyses of available data find little or no evidence
for this association; although there is strong
evidence for heterogeneity between datasets. This
pattern of findings could arise for several reasons
including the presence of relatively rare risk
alleles on common haplotype backgrounds or the
functional interaction of two or more loci within
the gene. We previously described the importance
of a specific haplotype at the 30 end of DAT1, as
well as the identification of associated single
nucleotide polymorphisms (SNPs) within or
close to 50 regulatory sequences. In this study we
replicate the association of SNPs at the 50 end of
the gene and identify a specific risk haplotype
spanning the 50 and 30 markers. These findings
indicate the presence of at least two loci asso-
ciated with ADHD within the DAT1 gene and
suggest that either additive or interaction
effects of these two loci on the risk for ADHD.
Overall these data provide further evidence that
genetic variants of the dopamine transporter
gene confer an increased risk for ADHD.
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INTRODUCTION
Attention deficit hyperactivity disorder (ADHD) is one of
the most common and highly heritable behavioral disorders
in children. The disorder is characterized by the childhood
onset of age inappropriate and impairing levels of hyper-
activity, impulsivity and inattention (American Psychiatric
Association, 2000) that persists into adult life in around 65% of
cases, either as the full-condition or in partial remission
with persistence of symptoms associated with significant
clinical impairments [Faraone et al., 2006]. The risk to siblings
of ADHD probands is around four- to fivefold the population
risk and heritability is estimated to be around 76% [Faraone
et al., 2005]. The search for genetic variants that increase the
risk for ADHD has focused mainly on the neurotransmitter
systems involved in the response of ADHD symptoms to
dopaminergic and noradrenergic medications. Genetic asso-
ciations have been clearly demonstrated between ADHD and a
variable number tandem repeat (VNTR) polymorphism in the
dopamine D4 receptor gene and a simple sequence repeat
polymorphism that lies upstream to the dopamine D5 receptor
gene [Li et al., 2006]. Several other genes involved in the
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regulation of catecholamine neurotransmission are associated
with ADHD in three or more studies and show small yet
significant evidence of association [Asherson, 2004; Faraone
et al., 2005].
One of the most interesting findings replicated in several
studies is the association between the 10-repeat allele of a
VNTR located within the 30untranslated (30UTR) region of the
dopamine transporter gene (DAT1). The dopamine transporter
is the main site of action of stimulant medications,
which provide a marked and rapid reduction in the level of
ADHD symptoms. Yet a recent study found no overall effect in a
comprehensive meta-analysis of available association data
[Li et al., 2006]. Despite this, the association remains of
considerable interest due to the number of positive reports and
the presence of significant evidence of heterogeneity across the
datasets, indicating that a subset of datasets may show true
association [Li et al., 2006]. One potential cause of hetero-
geneity could occur if only a subset of individuals carrying the
10-repeat allele is at risk for ADHD. This could arise if
the DAT1 risk allele interacts with additional genetic or
environmental risk factors, which vary in frequency in
different populations. For example data from several authors
have indicated potential interactions with prenatal environ-
mental risks [Kahn et al., 2003; Brookes et al., 2006a; Neuman
et al., 2007].
An alternative explanation, supported by recent data, is
that the 10-repeat allele is not the causative allele itself, but
rather ‘tags’ a nearby functional variant that is only partially
correlated with the 10-repeat allele, or that the 10-repeat allele
interacts with a second locus within the DAT1 gene [Asherson
et al., 2007]. Evidence for this comes from the observation in
several studies that specific DAT1 haplotypes containing
the 10-repeat allele confer risk for ADHD [Barr et al., 2001;
Greenwood et al., 2002; Hawi et al., 2003; Galili-Weisstub
et al., 2005; Brookes et al., 2006a]. A key finding from our own
research was the observation in two independent samples from
the UK and Taiwan of association between ADHD and a
specific haplotype of the 10-repeat allele with the 6-repeat
allele of a VNTR located in intron 8 [Brookes et al., 2006a]. This
finding was subsequently replicated in the first set of samples
(ST1) from the International Multi-centre ADHD Genetics
(IMAGE) project, using a large sample of ADHD combined
subtype cases [Asherson et al., 2007].
In an earlier study, the IMAGE ST1 samples were also
screened for association with 32 SNPs and two VNTRs
spanning DAT1, as part of a study that included the analysis
of 51 candidate genes [Brookes et al., 2006b]. None of the
markers were significant when adjusted for the number of
markers investigated, but we reported significant gene-
wide association for the sum of chi-squares for SNP associa-
tions across the gene. The analysis of two additional VNTR
markers located within introns 3 and 14 was subsequently
completed. To summaries the data from ST1, we found six
SNP markers and three VNTR markers showing nominal
evidence of association with combined type ADHD (P 0.05,
Table I). The association signal fell into two groups of
markers at the 30 and 50 ends of the gene. Genetic variants
within each region were found to be in high linkage
disequilibrium (LD), but there was low LD between the two
regions, suggesting the presence of two independent loci
associated with ADHD. In this study we extend these findings
by investigating the association of four SNP markers in the 30
and 50 region (two from each region) that were associated with
ADHD in the ST1 sample, in a second set of samples (ST2)
collected by the IMAGE consortium. We further analyze the
entire dataset and look for evidence of additive effects between
the two ends of the gene.
METHODS
The IMAGE Sample
European Caucasian subjects were recruited from twelve
specialist clinics in eight countries: Belgium, Germany,
Holland, Ireland, Israel, Spain, Switzerland, and United
Kingdom. Ethical approval for the study was obtained from
National Institute of Health registered ethical review boards
for each centre. Detailed information sheets were provided and
informed consent obtained from the majority of children and
from all of their parents. All ADHD probands and their siblings
were aged 5–17 at the time of entry into the study and access
was required to one or both biological parents for DNA
collection. Entry criteria for probands were a clinical diagnosis
of DSM-IV combined subtype ADHD and having one or more
full siblings available for ascertainment of clinical information
and DNA collection. Exclusion criteria applying to both
probands and siblings include autism, epilepsy, IQ< 70, brain
disorders and any genetic or medical disorder associated with
externalizing behaviors that might mimic ADHD. Inclusion
criteria included white European ancestry and living at home
with at least one biological parent.
The diagnosis of ADHD was made following a parent
interview with the Parental Account of Child Symptoms
interview [PACS; Taylor et al., 1986] that asks about ADHD
symptoms in various settings. An algorithm was used to derive
each of the DSM-IV ADHD symptoms from the PACS interview
data and these were combined with items that scored two or
more from teacher ratings of DSM-IV items taken from the long
version of the Conners’ Teacher Rating Scale [Conners, 1995].
The diagnosis of ADHD was made if sufficient items were
identified to fulfill DSM-IV criteria, and both impairment
(based on severity of symptoms identified in the PACS
interview) and pervasiveness (based on the presence of ADHD
symptoms in more than one setting from PACS and scoring
more than one item on the teacher Connors) were present. In
28 cases where no Connors data was present pervasiveness
was defined on the basis of PACS data alone [Brookes et al.,
2006b]. Further details on the clinical evaluation of the ADHD
probands can be found in the original study of 51 candidate
genes in the ST1 sample [Brookes et al., 2006b].
TABLE I. Markers Within the IMAGE Stage 1 Dataset (ST1) Displaying Nominal Significance (P 0.056) for Association With ADHD
Marker Position (bp) Location MAF P value Allele T NT OR
30UTR VNTR — 30UTR 0.29 0.03 10-repeat 277 245 1.13
Intron 14 VNTR — Intron 14 0.07 0.06 Insertion 106 80 1.33
rs40184 1,448,077 Intron 13 0.44 0.005 G 349 278 1.26
rs3776513 1,460,104 Intron 10 0.18 0.05 C 183 147 1.24
Intron 8 VNTR — Intron 8 0.22 0.006 6-repeat 243 207 1.17
rs2652511 1,499,389 50 Flanking 0.41 0.02 G 353 293 1.20
rs11564750 1,500,762 50 Flanking 0.09 0.03 G 127 94 1.35
rs10070282 1,503,444 50 Flanking 0.42 0.01 A 358 294 1.22
rs2550946 1,503,513 50 Flanking 0.42 0.007 G 358 289 1.24
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Stage 2 (ST2) Sample and Combined
ST1þST2 Sample
We previously reported DAT1 genotype data from the
analysis of the ST1 sample, which consisted of 776 DSM-IV
combined type ADHD cases with DNA from both parents
available for 90% of families and from one parent in 7% of
families [Brookes et al., 2006b]. In this study we report on new
data from the ST2 sample consisting of a further 435 combined
type probands (376 probands plus 59 affected siblings). DNA
was available from both parents in 80% of the families and from
one parent in 19.2% of the families. Following the accumu-
lation of further clinical information and a comprehensive
audit of the entire clinical and DNA datasets completed in April
2007, the final set of individuals with combined type ADHD
and fulfilling all inclusion and exclusion criteria in ST1 and
ST2 were amended: the final combined ST1 and ST2 dataset
used in this study consisted of 1,147 individuals with DSM-IV
combined subtype ADHD from 988 affected probands and 150
of their affected siblings.
Genotyping and SNP Selection
The initial scan of ST1 samples identified two clusters of
associated SNP markers at the 30 and 50 ends of the gene
[Brookes et al., 2006b]. From these we selected two SNPs from
the 30 region (rs40184 and rs3776513) and two located in the
50 region (rs2550946 and rs11564750). Since three of the
associated 50 SNPs in the ST1 study were found to be in
strong LD with an average r2 of 0.97 (rs2622511, rs2550946,
rs10070282) we selected only one (rs2550946) for analysis in
ST2, whereas the other marker we selected (rs11564750) was
only weakly associated with this group of SNPs (average r2 of
0.14). Genotyping of the 30UTR and intron 8 VNTRs were
previously carried out in the ST2 sample and the results
reported elsewhere [Asherson et al., 2007].
The SNP markers were genotyped using the ABI SNPlex
[Tobler et al., 2005] and ABI TaqMan genotyping protocols
(Applied Biosystems, Foster City, CA). The selected markers
were initially analyzed on the ABI SNPlex system. Due to a
high failure rate with the SNPlex assays, genotypes were
repeated using the ABI TaqMan assay. We found no discrep-
ancies in overlapping genotypes using the two methods.
Standard protocols provided by ABI were followed for both
types of assays. Three SNP assays were designed for the
TaqMan 7900HT: SNP rs40184 was available from ‘assays-
on-demand’, whilst SNP markers rs11564750 and rs2550946
were custom designed for the project. We were unable to design
a TaqMan assay for SNP rs3776513.
Analysis
The transmission disequilibrium test was performed for
probands with the combined subtype of ADHD using the
UNPHASED program (TDTPHASE; [Dudbridge, 2003, www.
rfcgr.mrc.ac.uk/fdudbrid/software/unphased]. Nominal evi-
dence for association was determined by P-values less than
0.05 and adjusted significance estimated by permutation
tests. In addition we utilized the WHAP program to conduct
conditional analyses that test the contribution of genetic
variants to haplotype associations (www.genome.wi.mit.edu/
shaun/whap). In the conditional test a SNP is dropped
from the null model and compared to the alternative model. A
significant P-value indicates that the dropped SNP has an
independent effect and makes a significant contribution to the
haplotype association.
RESULTS
LD Across the Gene
Using the data from the ST1 study, we examined the LD
structure across the gene, with values provided from the
UNPHASED software package [Genro et al., 2007] (Fig. S1).
Observation of D0 values indicate that there are four main LD
blocks: one of the LD regions spans the 30UTR, another spans
intron 11 to intron 8, a third spans exon 5 to intron 2 (rs403636)
and a fourth spans the 50UTR and upstream flanking
region. These data indicate that the two regions of ADHD-
associated markers identified at the 30 and 50ends of the
gene in the previous study represent independent SNP
clusters and cannot be explained by one set of SNPs tagging
the other.
Replication Study
Genotype data from the four SNPs in the ST2 dataset showed
similar minor allele frequencies to those observed in the ST1
study (Table II). The four SNPs were in Hardy–Weinberg
equilibrium and had a genotype success rate of over 97%;
except for rs3776513, which could not be genotyped on the
TaqMan platform and only 77% of the ST2 genotypes could be
reliably called from the SNPlex assay. TDT analysis found that
two of the four SNP markers showed nominal significance
(P< 0.01) and surpassed the Bonferroni correction for the four
markers tested: rs11564750 located in the 50 promoter region
and rs3776513 located within intron 10 (Table II). For both
these SNP markers the same allele was preferentially trans-
mitted in both the ST1 and ST2 datasets. The remaining two
SNP markers rs2550946 (50-region), and rs40184 (intron 13)
were not significantly associated, however both SNP markers
showed over-transmission of the same allele observed to be the
risk allele in the ST1 dataset. In the combined analysis of
the ST1 and ST2 datasets, nominally significant associations
were observed for all four SNP markers with estimated odds
ratios in the range 1.2–1.5.
TABLE II. Findings From TDT Analysis of the ST1, and ST2 Datasets Independently and When Combined
SNP ID Position (bp) Location Dataset Minor allele MAF TDT P value Risk allele T NT OR
rs2550946 1,503,513 50 Promoter ST1 A 0.42 0.006 G 358 289 1.24
ST2 A 0.41 0.45 G 131 119 1.1
ST1 and ST2 A 0.42 0.01 G 485 408 1.19
rs11564750 1,500,762 50 Promoter ST1 C 0.09 0.03 G 127 94 1.35
ST2 C 0.1 0.004 G 67 38 1.76
ST1 and ST2 C 0.09 0.0006 G 195 133 1.47
rs3776513 1,460,104 Intron 10 ST1 T 0.18 0.05 G 183 147 1.24
ST2 T 0.21 0.01 G 80 51 1.57
ST1 and ST2 T 0.19 0.009 G 247 193 1.28
rs40184 1,448,077 Intron 13 ST1 T 0.44 0.005 C 349 278 1.26
ST2 T 0.46 0.31 C 149 132 1.13
ST1 and ST2 T 0.45 0.005 C 498 414 1.2
MAF, minor allele frequency.
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Haplotype Analysis and Conditional Tests
Haplotype analysis was performed for the four markers
genotyped in both the ST1 and ST2 datasets (Table III).
Pair-wise haplotype analysis indicated that the most signifi-
cant finding occurred between rs2550946 in the 50promoter
region and rs40184 in intron 13 (P< 0.00002). These
two markers lie over 55 kb apart and have an estimated r2 of
0.02 for transmitted alleles and an r2 of 0.0002 for non-
transmitted alleles. The four-marker haplotype has a global
P-value of 0.0001 with only one haplotype (GGGC) displaying
significant over transmission to ADHD probands (haplotype-
specific P-value¼ 1.8 106): these alleles coincide with those
transmitted in the single marker analysis (Table IV).
WHAP analysis confirmed the haplotype association, but
with reduced significance using the permutation routine
(P¼ 0.004). When testing the effect of dropping each marker
from the two marker haplotypes, a significant difference of
fit was observed for both rs40184 (P¼ 0.008) and rs2550946
(P¼ 0.03). These findings indicate that independent markers
at the 30 and 50 ends of the genes both contribute significantly to
the haplotype association. In contrast, when the two 30 SNP
marker and the two 50 SNP marker haplotypes were examined
it was found that one of the two markers from each group could
be dropped from the analysis, indicating that no additional
information was obtained from the analysis of haplotypes
within the 30 and within the 50 SNP clusters.
DISCUSSION
There are two main novel findings in this study. First,
we replicate earlier evidence of association with between
ADHD and SNP markers that span genetic variation in the
50regulatory region of DAT1, including the promoter region.
Second we show that markers that form independent SNP
clusters at the 30 and 50 ends of the gene contribute significantly
to a specific haplotype association. This is a key finding that
suggests two independent functional sites within the DAT1
gene associated with ADHD.
The ST2 IMAGE samples used in this study provide a small
but clinically homogenous sample that was ascertained using
identical clinical procedures to the ST1 sample. For this reason
replication is feasible despite the relatively small sample size of
ST2 compared to ST1. The selection of the four SNP markers
was based on nominally significant associations observed in
the ST1 study [Brookes et al., 2006b] with two SNP markers
selected from each of two associated SNP clusters. Significant
association with ADHD was observed for two of the markers
rs11564750 and rs3776513 located in the 50 promoter region
and intron 10, respectively, which is a direct replication of
findings from ST1. Although the other two SNPs were not
significantly associated with ADHD in ST2, they showed the
same direction of effect for over-transmission of alleles to
affected offspring. Analysis of the two SNPs that were not
associated with ADHD in ST2 might also lack power, because
they had relatively high minor allele frequencies compared to
the significantly associated SNPs.
Several other groups have also identified SNP associations
with ADHD in the 50 region of DAT1. Genro et al. [2007] using a
sample of ADHD probands from Brazil detected association to
the same allele of rs2652511 reported in this study. Further-
more, they found that the effect size for this association was
greater when they restricted their analysis to the subset of
individuals with combined type ADHD. Ohadi et al. [2006]
found association of ADHD with the T-allele of a core promoter
SNP at position –67 (rs2975226) which is thought to possess
functional properties. The T-allele of this SNP creates a
putative SIF-binding element [Rubie et al., 2001] capable of
increasing transcription by twofold [Greenwood et al., 2002;
Greenwood and Kelsoe, 2003]. This putative functional SNP
lies 4.8 kb downstream from (and is in high LD with) SNP
rs2550946 that is associated with ADHD in this study; and only
774 bp from SNP rs2652511 that was associated with ADHD
in the ST1 study [Brookes et al., 2006b]. This SNP also lies in a
region of highly conserved sequence identity (63%) between the
mouse and human 50 flanking regions [Donovan et al., 1995].
Finally, Friedel et al. [2007] recently completed a comprehen-
sive analysis of 30 SNPs spanning the 30and 50regions of
DAT1 in a sample of ADHD cases from Germany. One of the
associated markers identified in their study (rs403636) showed
the same allelic association to that reported in our ST1 study
but did not clearly identify an overlapping haplotype with that
reported in this study.
The finding of replicated association with SNPs within the 50
regulatory region of DAT1 is clearly of key interest and further
work is needed to delineate the role of functional variation in
this region. Drgon et al. [2006] reported that the rs2550946
is involved in altered transcriptional regulation, with the
C-allele promoting Rps3a-2-homol-D transcription factor bind-
ing, whereas the T-allele promotes GHFI/Pit1-pr-1 binding.
Based on the association with the C-allele in this study the
association with ADHD might be mediated by increased
binding of the transcription factor Rps3a-2-homol-D in ADHD
cases. Drgon et al. [2006] also reported that the C-allele of SNP
rs2652511, that was associated with ADHD in this study and is
in strong LD with rs2550946, is associated with significantly
higher levels of DAT1 expression in vivo.
The second key finding from this study was the contribution
of genetic variants to the risk for ADHD from both the 30 and
50 regions. However, it is not clear from the analysis of
TABLE III. Significance Values for Two-Marker Haplotypes for
the SNP Markers Investigated in the Combined ST1 and ST2
Dataset Are Located in the Upper Triangle
rs2550946 rs11564750 rs3776513 rs40184
rs2550946 0.0004 0.004 0.00002
rs11564750 0.16 0.0004 0.0002
rs3776513 0.0004 0.05 0.01
rs40184 0.02 0.002 0.08
Linkage disequilibrium values determined by r2 are present in the lower
triangle.
TABLE IV. The Transmission of Alleles in a Four-Marker
Haplotype
rs2550946 rs11564750 rs3776513 rs40184 T NT OR
A C G C 43 54 0.80
A C G T 26 29 0.90
A C T C 0 9 0.00
A C T T 5 12 0.42
A G G C 142 137 1.04
A G G T 112 119 0.94
A G T C 2 4 0.50
A G T T 56 54 1.04
G C G C 1 3 0.33
G C G T 0 1 0.00
G C T C 0 1 0.00
G G G C 279 177 1.58
G G G T 122 149 0.82
G G T C 28 32 0.88
G G T T 48 83 0.58
Only one risk haplotype is observed highlighted in bold.
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association data alone what are the genetic sequences within
these regions that are the primary source of the association
signals. No single marker was responsible for the haplotype
association and the evidence from WHAP indicated that the
presence of genetic variation in both regions was important.
The finding that only a single haplotype spanning the four SNP
markers in this study was associated with increased risk for
ADHD (odds ratio¼ 1.58, global P¼ 0.00016, haplotype spe-
cific P¼ 1.7 106) suggests a possible interaction between the
two loci, but could also arise from a simple additive effect of two
main associated loci. The possibility that risk variants at more
than one site are required to enhance the risk for ADHD could
contribute to the observed heterogeneity see within meta-
analytic studies of DAT1 [Li et al., 2006].
The functional role of the two VNTR markers located within
the 30UTR and intron 8 in our earlier study also remains
uncertain. In our previous report we found evidence for a
contribution of both loci to a haplotype association between the
two VNTRs [Asherson et al., 2007], however it was not possible
to distinguish between two possible explanations. First that
the two VNTR markers tag a single (unidentified) functional
site; and second that there is a functional interaction between
two VNTR markers (or closely associated functional variants).
It is also feasible that the two VNTRs mark two independent
loci with purely additive effects at the level of gene function. We
have also analyzed the VNTR markers in relation to the SNPs
investigated in this study and found that they formed part of
the same 30 haplotype reported here (data not shown).
We therefore conclude that analysis of DAT1 in the IMAGE
dataset suggests the presence of two and potentially three
functional loci.
In summary we have replicated association findings between
ADHD and genetic variants within DAT1, that were initially
identified as nominal associations in a scan of SNP markers
tagging genetic variation across 51 candidate genes. Limita-
tions of this study include possible heterogeneity arising from
the use of a multisite European sample, although this is largely
controlled by the use of the Transmission Disequilibrium Test
as our primary tool for association analysis. A further problem
was the relatively small sample size of this study compared to
the initial ST1 study, which might account for replication of
only two out of the four markers studied. The overall findings in
the combined IMAGE dataset suggest that there may additive
or interactional effects of two or more functional loci within
DAT1. Further analysis of the functional consequences of
genetic variation within the gene is therefore required and
replication and meta-analytic studies in independent datasets
are required to confirm or refute the pattern of findings
reported here.
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